Dr. Rakesh K. Bhardwaj, MD

Dr. Bhardwaj practices at Rakesh K. Bhardwaj, MD, PC in Queens Village, New York.

Dr. Bhardwaj's NPI, 1265511877, was assigned on November 3, 2006. Dr. Bhardwaj graduated from G.S.V.M Medical College Kanpur in 1977. Dr. Bhardwaj holds New York license 187625.

Dr. Bhardwaj's primary practice is Rakesh K. Bhardwaj, MD, PC, at 8945 Springfield Blvd, Queens Village, NY 11427-2513. The practice phone is (718) 217-2300.

Dr. Bhardwaj's primary practice is Rakesh K. Bhardwaj, MD, PC in Queens Village, New York. Dmand AI also links Dr. Bhardwaj to 3 skilled nursing facilities, 1 home health agency and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhardwaj practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Bhardwaj's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Bhardwaj is licensed in New York.

Dmand AI lists asthma, bronchitis, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, chronic sinusitis, pulmonary fibrosis, pulmonary heart disease and sleep apnea among the conditions Dr. Bhardwaj treats.

CMS data shows 4,652 Medicare services from Dr. Bhardwaj across 19 procedure codes in 2024, for 398 Medicare patients. Medicare paid $282,010 for them.

CMS counts 398 Medicare patients who saw Dr. Bhardwaj in 2024. The largest group is 85 and over, with 138 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 54% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bhardwaj's median patient age at 75, with 52% women.

In 2024, Dr. Bhardwaj wrote 13,304 Medicare Part D claims for 646 patients. 78% of them were for generic drugs. CMS names the drug for 12,450 of them, across 188 drugs with 11 or more claims each, at $1,012,674 in total drug cost. In 2023, CMS named 11,028 claims across 169 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Bhardwaj for performance year 2024, reported individually. Dr. Bhardwaj accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 40 papers to Dr. Bhardwaj, published from 2016 to 2025. 2024 was the busiest year, with 12. The most frequent topics are Genome-Wide Association Study, Genotype and Nutritive Value. Dr. Bhardwaj has published most often in Front Nutr. Dr. Bhardwaj's most frequent co-authors are Kuldeep Singh, Manish Kumar and Kiran B. Hebbar, MD.

CMS Open Payments shows 89 general payments to Dr. Bhardwaj from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. AstraZeneca Pharmaceuticals LP paid the most, $640.

Dr. Bhardwaj graduated from G.S.V.M Medical College Kanpur in 1977.

Dr. Bhardwaj is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.